Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2,181,288,547
-
Number of holders
-
1,134
-
Total 13F shares, excl. options
-
218,133,501
-
Shares change
-
-9,239,012
-
Total reported value, excl. options
-
$18,649,888,527
-
Value change
-
-$803,320,984
-
Put/Call ratio
-
48.2%
-
Number of buys
-
468
-
Number of sells
-
-544
-
Price
-
$85.48
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q1 2021
1,267 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q1 2021.
NOVARTIS AG - Ordinary Shares (NVS) has 1,134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 218,133,501 shares
of 2,181,288,547 outstanding shares and own 10% of the company stock.
Largest 10 shareholders include Dodge & Cox (21,670,237 shares), PRIMECAP MANAGEMENT CO/CA/ (20,543,800 shares), LOOMIS SAYLES & CO L P (19,768,777 shares), Fisher Asset Management, LLC (9,657,603 shares), BANK OF AMERICA CORP /DE/ (9,189,032 shares), FRANKLIN RESOURCES INC (8,444,411 shares), Aristotle Capital Management, LLC (7,908,653 shares), Boston Partners (5,860,571 shares), WELLS FARGO & COMPANY/MN (5,812,499 shares), and UBS Group AG (5,031,466 shares).
This table shows the top 1,134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.